Teladoc Health (TDOC) Stock Price, News & Analysis

Company Overview

Teladoc Health, Inc. is a leading global provider of virtual healthcare services, offering on-demand medical consultations via phone, video, and mobile app platforms. The company connects patients with licensed physicians and specialists for non-emergency medical issues, mental health support, dermatology, and chronic condition management. By leveraging digital technologies and data analytics, Teladoc aims to enhance accessibility, reduce healthcare costs, and improve patient outcomes through personalized care plans and remote monitoring.

Teladoc’s service portfolio includes general medical visits, behavioral health sessions, expert medical services for complex cases, and wellness programs designed to support chronic disease management such as diabetes, hypertension, and heart disease. The company also provides integrated virtual care solutions that combine live consultations with remote patient monitoring devices, enabling continuous health tracking and proactive intervention. In 2020, Teladoc expanded its capabilities through the acquisition of Livongo Health, a leader in digital chronic condition management, thereby strengthening its population health offerings.

With headquarters in Purchase, New York, Teladoc operates in more than 175 countries and serves a diverse client base that includes employers, health plans, hospitals, and health systems. The company maintains regional operations in North America, Latin America, Europe, and the Asia Pacific region, adapting services to meet local regulatory requirements and healthcare needs. Strategic partnerships with insurers and healthcare providers help Teladoc integrate virtual care into existing care pathways and insurance networks.

Founded in 2002 by Michael Gorton and Byron Brooks, Teladoc has evolved from a telephonic medical consultation service into a comprehensive virtual care platform. Jason Gorevic has served as Chief Executive Officer since 2009, guiding the company through rapid expansion, technology innovation, and multiple acquisitions. Under his leadership, Teladoc continues to invest in digital health solutions, artificial intelligence, and data-driven tools to support the future of connected care.

Key Stats

• Today's Range: $7.84 to $8.29
• 50-Day Range: $5.55 to $8.07
• 52-Week Range: $4.40 to $9.77
• Volume: 1.11 million shs
• Average Volume: 5.51 million shs
• Market Capitalization: $1.50 billion
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: $7.43
• Consensus Rating: Hold

Teladoc Health Stock Analysis - MarketRank™

Teladoc Health scored higher than 19% of companies evaluated by MarketBeat, and ranked 736th out of 848 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.5 / 5
• Analyst Rating: Hold

Consensus Rating

Teladoc Health has received a consensus rating of Hold. The company's average rating score is 2.24, and is based on no strong buy ratings, 5 buy ratings, 11 hold ratings, and 1 sell rating.

Downside Risk

Teladoc Health has a consensus price target of $7.43, representing about 5.8% downside from its current price of $7.90.

Amount of Analyst Coverage

Teladoc Health has only been the subject of 2 research reports in the past 90 days.

Earnings and Valuation

• Score: 0.6 / 5
• Proj. Earnings Growth: Growing

Earnings Growth

Earnings for Teladoc Health are expected to grow in the coming year, from ($0.92) to ($0.79) per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Teladoc Health is -8.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Earnings Ratio vs. Sector

The P/E ratio of Teladoc Health is -8.14, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Teladoc Health has a P/B Ratio of 1.01. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 1.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

16.42% of the float of Teladoc Health has been sold short.

Short Interest Ratio / Days to Cover

Teladoc Health has a short interest ratio ("days to cover") of 7.39.

Change versus previous month

Short interest in Teladoc Health has recently increased by 6.24%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Teladoc Health does not currently pay a dividend.

Dividend Growth

Teladoc Health does not have a long track record of dividend growth.

News and Social Media

• Score: 2.3 / 5
• News Sentiment: 0.71

News Sentiment

Teladoc Health has a news sentiment score of 0.71. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.97 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 4 news articles for Teladoc Health this week, compared to 6 articles on an average week.

Search Interest

Only 18 people have searched for TDOC on MarketBeat in the last 30 days. This is a decrease of -62% compared to the previous 30 days.

MarketBeat Follows

6 people have added Teladoc Health to their MarketBeat watchlist in the last 30 days. This is an increase of 500% compared to the previous 30 days.

Company Ownership

• Score: 1.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Teladoc Health insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $302,507.00 in company stock.

Percentage Held by Insiders

0.70% of the stock of Teladoc Health is held by insiders.

Percentage Held by Institutions

76.82% of the stock of Teladoc Health is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Last Earnings: 4/29/2026
• Today: 6/26/2026
• Next Earnings (Estimated): 7/29/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NYSE
• Sector: Medical
• Industry: Medical Services
• Sub-Industry: Healthcare
• Current Symbol: NYSE:TDOC
• CIK: 1477449
• Web: www.teladochealth.com
• Phone: (203) 635-2002
• Fax: N/A
• Employees: 5,600
• Year Founded: 2002

Price Target and Rating

• Average Price Target for Teladoc Health: $7.43
• High Price Target: $11.00
• Low Price Target: $5.00
• Potential Upside/Downside: -9.5%
• Consensus Rating: Hold
• Rating Score (0-4): 2.24
• Research Coverage: 17 Analysts

Profitability

• EPS (Trailing Twelve Months): ($0.97)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$200.32 million
• Net Margins: -6.81%
• Pretax Margin: -7.36%
• Return on Equity: -11.45%
• Return on Assets: -5.54%

Debt

• Debt-to-Equity Ratio: 0.75
• Current Ratio: 2.80
• Quick Ratio: 2.72

Sales & Book Value

• Annual Sales: $2.53 billion
• Price / Sales: 0.59
• Cash Flow: $1.89 per share
• Price / Cash Flow: 4.34
• Book Value: $7.81 per share
• Price / Book: 1.05

Miscellaneous

• Outstanding Shares: 180,510,000
• Free Float: 179,249,000
• Market Cap: $1.48 billion
• Optionable: Optionable
• Beta: 2.14